MYRIAD AFTER MYRIAD: THE PROPRIETARY DATA DILEMMA
Myriad Genetics' long-time monopoly on BRCA gene testing was significantly narrowed by the Supreme Court's decision in , and will be further narrowed in the next few years as many of its still-valid patents expire. But these developments have not caused the company to acquiesce in competit...
Gespeichert in:
Veröffentlicht in: | North Carolina journal of law & technology 2014-06, Vol.15 (4), p.597-637 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!